HWMG
EW icon

Harbour Wealth Management Group’s Edwards Lifesciences EW Stock Holding History

Harbour Wealth Management Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
2,956
+75
+3% +$6.28K 0.18% 80
2026
Q1 		$231K Buy
2,881
+103
+4% +$8.49K 0.17% 80
2025
Q4 		$237K Buy
+2,778
New +$228K 0.19% 83

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Harbour Wealth Management Group's EW Position: Q2 2026 in Review

Harbour Wealth Management Group increased its Edwards Lifesciences (EW) stake by 2.6% in Q2 2026, buying an estimated $6.28K and bringing the position to 2,956 shares worth $267K. The position accounts for 0.18% of the portfolio, ranked #80.

Harbour Wealth Management Group first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,329 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Harbour Wealth Management Group held 2,956 shares of Edwards Lifesciences worth $267K as of Q2 2026.
  • Harbour Wealth Management Group bought 75 Edwards Lifesciences shares in Q2 2026, an estimated $6.28K.
  • Edwards Lifesciences made up 0.18% of Harbour Wealth Management Group's portfolio in Q2 2026, its #80 holding.
  • Harbour Wealth Management Group first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 1,329 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Harbour Wealth Management Group's 13F filing for Q2 2026, filed 7 Aug 2026.